SLC27A5 and fatty liver disease: The results from Doege et al., using a FATP5-knockout mouse model, revealed that silencing FATP5 in vivo significantly improved whole-body insulin sensitivity and reversed fat-diet-induced obesity and even fatty liver disease [12].